Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
CRANBERRY FRUIT DRY JUICE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In USP Reference Standards 〈11〉: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS |
FOSAMPRENAVIR CALCIUM TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Dissolution 〈711〉/Medium: Change 26.7 g/L of sodium acetate trihydrate in water. Add 133 mL of glacial acetic acid to this solution, and then dilute with water to 10 L; 900 mL. to: 0.02 M sodium acetate buffer, pH 3.5, prepared as follows.… Read More |
OCTOCRYLENE | IDENTIFICATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In A./Acceptance criteria: Change NMT 3.0%, calculated on the as-is basis to: Absorptivities, calculated on the as-is basis, do not differ by more than 3.0%. |
ZIPRASIDONE CAPSULES | ASSAY | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Procedure/Analysis: Change 449.40 to: 449.39 |
ZIPRASIDONE CAPSULES | PERFORMANCE TESTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Dissolution 〈711〉/Test 1/Tier 1/Phosphate buffer, pH 7.5: Change sodium hydroxide to: sodium hydroxide solution AND In Dissolution 〈711〉/Test 1/Tier 1/Analysis: Change 449.40 to… Read More |
ZIPRASIDONE CAPSULES | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Solution B: Change potassium hydroxide to: potassium hydroxide solution AND In Organic Impurities/Analysis: Change 449.40 to: 449.39 |
ZIPRASIDONE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Solution B: Change Acetonitrile, methanol, and Buffer (55:5:40). Adjust with potassium hydroxide TS to a pH of 6.0. to: Acetonitrile, methanol, and Buffer (55:5:40). Adjust with potassium hydroxide solution… Read More |
AZITHROMYCIN | CHEMICAL INFORMATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change 748.98 to: 749.00 AND Change 767.00 to: 767.01 AND Change 785.02 to: 785.03 |
AZITHROMYCIN | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Table 2: Change: 3′-N-{[4-(Acetylamino)phenyl]sulfonyl}-3′-demethylazithromycinm to: 3’-N-Demethyl-3’-N-[(4-methylphenyl)sulfonyl]azithromycinm AND In Organic Impurities… Read More |
AZITHROMYCIN | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Azaerythromycin A RS: Change 734.96 to: 734.97 AND In USP Azithromycin Related Compound F RS: Change 762.97 to: 762.98 AND In USP Desosaminylazithromycin RS: Change 590.79 to: 590.80 |
VALGANCICLOVIR HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Table 3/footnote c: Change 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-2-hydroxypropyl methyl-L-valinate hydrochloride. to: 3-[(2-Amino-6-oxo-1,6-dihydropurin-9-yl)methoxy]-2-hydroxypropyl L… Read More |
DIGOXIN TABLETS | ASSAY | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Procedure/Analysis: Change CU = nominal concentration of in the Sample solution (µg/mL) to: CU = nominal concentration of digoxin in the Sample solution (µg/mL) |
DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Dissolution 〈711〉/Test 8/Tolerances: Change The percentage of the labeled amount of valproic acid (C8H16O2) dissolved at the times specified conform to Dissolution <711>, Acceptance… Read More |
TAMSULOSIN HYDROCHLORIDE CAPSULES | IMPURITIES | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Organic Impurities/System suitability: Change Sample: Standard solution [Note—The relative retention times for methoxy tamsulosin, tamsulosin, ethoxyphenoxy ethyl bromide, and desethoxy tamsulosin are 0.73, 1.00, 1.80… Read More |
<430> PARTICLE SIZE ANALYSIS BY DYNAMIC LIGHT SCATTERING | GLOSSARY | USPNF Online | Online | 27-Oct-2023 | 1-May-2024 | NA | NA | In Average particle diameter: Change expressed in nanometers. to: expressed in meters. AND In Viscosity: Change in millipascal-seconds (mPa・s). to: in pascal-seconds (Pa・s). |
METHYLBENZETHONIUM CHLORIDE | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/Analysis: Change Calculate the percentage of methylbenzethonium chloride (C28H44ClNO2 · H2O) in the portion of Methylbenzethonium Chloride taken: to: Calculate the percentage of… Read More |
UREA | SPECIFIC TESTS | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Alcohol-Insoluble Matter/Sample solution: Change 100 mg/mL of Urea dissolved in warm alcohol to: Dissolve 5.0 g of Urea in 50 mL of warm alcohol. AND In Alcohol-Insoluble Matter/Analysis: Change If any insoluble… Read More |
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/System suitability/Tailing factor: Change NMT 2.0, System suitability solution to: NMT 2.0 for pantoprazole, System suitability solution |
OIL- AND WATER-SOLUBLE VITAMINS WITH MINERALS CAPSULES | STRENGTH | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Vitamin A, Method 3/Analysis: Change CS = concentration of retinyl acetate (C23H32O2) from USP Vitamin A RS in the Standard solution (μg/mL) to: CS = concentration… Read More |
OIL-SOLUBLE VITAMINS CAPSULES | STRENGTH | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Vitamin A, Method 3/Analysis: Change CS = concentration of retinyl acetate (C23H32O2) from USP Vitamin A RS in the Standard solution (μg/mL) to: CS = concentration… Read More |
AMOXICILLIN FOR INJECTABLE SUSPENSION | Identification | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | Change Prepare a test solution containing the equivalent of 4 mg of amoxicillin per mL by adding 0.1 N hydrochloric acid to Amoxicillin for Injectable Suspension. Allow the solution to stand for 5 minutes before use: the solution responds to the Identification… Read More |
TELMISARTAN TABLETS | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/System suitability/Suitability requirements: Change Resolution: NLT 3 between telmisartan and telmisartan related compound A Tailing factor: NMT 2.0 for the telmisartan peak Capacity factor: NLT… Read More |
TELMISARTAN TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Dissolution 〈711〉/Test 1/Analysis: Change Determine the percentage of telmisartan (C33H30N4O2) dissolved: Result = (AU × CS × V × 100)/(A… Read More |
<631> COLOR AND ACHROMICITY | METHOD II: INSTRUMENTAL (QUANTITATIVE) ASSESSMENT OF COLOR AND COLOR MATCHES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Table 5: Change Sum 98.809 100.000 107.307 White point 98.811 100.000 107.304 to: Sum 94.809 100.000 107.307 White point 94.811 100.000 107.304 |
<915> MEASUREMENT OF STRUCTURAL STRENGTH OF SEMISOLIDS BY PENETROMETRY | APPARATUS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Figure 2: Change 66±0.25 Ø to: 65±0.25 Ø |
AMIKACIN SULFATE | ASSAY | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Procedure/Analysis: Change CU = concentration of amikacin in the Sample solution (mg/mL) to: CU = concentration of Amikacin Sulfate in the Sample solution (mg/mL) |
AMOXICILLIN BOLUSES | IDENTIFICATION | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | Change Application volume, Developing solvent system, Procedure—Proceed as directed for the Identification test under Amoxicillin Tablets. to: Application volume—5 µL. Developing solvent system… Read More |
AMOXICILLIN INTRAMAMMARY INFUSION | IDENTIFICATION | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | Change The solution obtained responds to the Identification test under Amoxicillin Capsules. to: Prepare a Standard solution of USP Amoxicillin RS in 0.1 N hydrochloric acid containing 4 mg per mL. Use within 10 minutes after preparation.… Read More |
AZITHROMYCIN | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2: Change 3'-N-Demethyl-3'-N-[(4-methylphenyl)sulfonyl]azithromycinm to: 3′-N-{[4-(Acetylamino)phenyl]sulfonyl}-3′-demethylazithromycinm AND In Table 2/footnote m… Read More |
DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉: Move Test 2 after Test 1 |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test for dutasteride/Tier 2/Medium: Change 10 g/L of cetyltrimethylammonium bromide and 750,000 USP units of activity/mg of pepsin, purified in 0.1 N hydrochloric acid; 900 mL to: Dissolve 10 g of… Read More |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Dihydrodutasteride RS: Change N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide. to: N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androstane-17β-carboxamide. |
NORFLURANE | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2: Change Line No. to: Peak Elution Order AND In Halides/Figure 1: Add label Flow Meter |
OLMESARTAN MEDOXOMIL TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test 5/Apparatus 2: Change 50 rpm. Use peak vessels. to: 50 rpm. Use apex vessels. |
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test 2/Acid stage: Change Acid stage standard solution: (L/10) mg/mL of USP Pantoprazole Sodium RS from the Standard stock solution in Acid stage medium, where L is the label claim… Read More |
SODIUM SALICYLATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉: Add USP Phenol RS |
Strychnine Sulfate | REAGENTS AND REFERENCE TABLES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Reagent Specifications: Change CAS RN®: 60-41-3. to: CAS RN®: 60491-10-3. |
CEFDINIR | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2/footnote a: Change 1N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. to: N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. |
CEFDINIR | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 |
CEFDINIR CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
CEFDINIR FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
<81> ANTIBIOTICS—MICROBIAL ASSAYS | APPENDICES | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | In two instances in Appendix 1 equations: Change 14.020 to: 14.022 |
ACARBOSE | IMPURITIES | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | In Chromatographic Purity/Analysis: Change Result = (rU/rA) × (1/F) × 100 to: Result = (rU/rA) × (1/F) |
GLUCAGON | PROCESS-RELATED IMPURITIES AND OTHER COMPONENTS | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | In Acetic Acid in Peptides/Analysis: Change CSPA = concentration of potassium acetate in each of the Standard solutions (mg/mL) to: CSPA = concentration of potassium acetate in each of the … Read More |
SECOBARBITAL SODIUM | OTHER REQUIREMENTS | USPNF Online | Online | 29-Dec-2023 | 1-Jan-2024 | NA | NA | Change Where the label states that Seco barbital Sodium is sterile, it meets the requirements for Sterility Tests 〈71〉 and for Bacterial endotoxins under Secobarbital Sodium for Injection. Where the label states that Secobarbital Sodium… Read More |
AMOXICILLIN ORAL SUSPENSION | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | Change Shake a portion of Oral Suspension with a mixture of acetone and 0.1 N hydrochloric acid (4:1) to obtain a solution containing about 1 mg of amoxicillin per mL. The solution responds to the Identification test under Amoxicillin Capsules.… Read More |
CARVEDILOL TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In Dissolution <711>/Test 3/Chromatographic system/Column: Change 4.6-mm × 15-mm; 5-μm packing L7 to: 4.6-mm × 15-cm; 5-μm packing L7 |
DICYCLOMINE HYDROCHLORIDE | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In B. Identification Tests—General 〈191〉, Chemical Identification Tests, Chloride: Change Meets the requirements when tested as specified in test B. to: Meets the requirements of the test for amine… Read More |
LINEZOLID TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In Dissolution 〈711〉/Test 1/Analysis: Change Result = (rU/rS) × CS × V × (1/L) × 100 rU = peak response of linezolid from the Sample… Read More |
THEOPHYLLINE CAPSULES | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | Change A: The contents of the Capsules respond to Identification tests A and B under Theophylline Tablets. B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds… Read More |